Smart implant breakthrough


MagLense, a wireless power innovation set to be a game changer for implants and wearables MagLense, a breakthrough in through body wireless power transfer from product design and development firm Cambridge Consultants is set to revolutionise the world of medical implants and consumer wearable devices. The system provides flexible, efficient and safe wireless power transfer …




Continue reading

George Church joins Nuclera’s Scientific Advisory Board


Cambridge, UK, 31 October 2017: Nuclera Nucleics Ltd., a Cambridge, UK-based enzymatic DNA synthesis company, announces the appointment of George Church, Professor of Harvard and MIT to the Nuclera Scientific Advisory Board. “Demand for custom DNA is growing exponentially – with applications in manufacturing, medicine, and even information storage”, said George Church. “Nuclera represents fresh approaches, …




Continue reading

Cambridge Consultants to develop custom DNA at lightning speeds


Automating DNA assembly to drive forward the engineering of biology and unlock new applications Product design and development firm Cambridge Consultants and SGI-DNA, a Synthetic Genomics Inc. company in San Diego, CA, USA, today announce that they will be installing the first BioXp™ 3200 System in the UK. The implementation will drive forward the use …




Continue reading

New Therapeutics Forum


A number of companies based on the Science Park have employees who are members of the New Therapeutics Forum and they are welcome to attend the next meeting. It is open to all scientists researching new therapeutics in Cambridge and the local area. Host: Cambridge Alliance on Medicines Safety (CAMS) Date: 3 October 2017 Location: …




Continue reading

Diamond Pharma Services Announce a Brexit Package


Brexit Package and Considerations Leaflet The negotiation for the final Brexit agreement and a new working-relationship between the EU and the UK still has many twists and turns ahead. From a medical perspective, the European Medicines Agency and EU Commission have published their expectations on the assumption of a Hard-Brexit scenario. The purpose of their …




Continue reading

Linguamatics announces University of Pennsylvania Health System as latest Enterprise NLP client


I2E Natural Language Processing advances research and care delivery by mining clinical insights from unstructured patient data Cambridge, UK & Boston, USA – June 20th, 2017 – Market leading Natural Language Processing (NLP) text analytics provider Linguamatics today announced the implementation of the Linguamatics Health enterprise NLP platform, powered by I2E, at the University of …




Continue reading